Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 02:30 ET | Source: Arecor Therapeutics PLC

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292

Arecor Therapeutics announces Co-development Agreement for AT278 with Sequel Med Tech and Sale of Royalty and Technology Access Fees for up to $11m